Observing that the domestically manufactured vaccines would be the backbone of vaccinating the Indian people, US Pharma giant Pfizer CEO Dr Albert Bourla has said that his firm is in the final stages of an agreement with India to supply anti-Covid-19 vaccines.
Addressing the 15th edition of the India-US Bio Pharma & Healthcare Summit, Dr Bourla also said that Pfizer has made a specific plan that the mid and low-income countries, which includes India, will receive at least two billion of such doses.
The Pfizer CEO said that a significant local manufacturing of vaccines that is happening at the Serum Institute of India will provide the “backbone of vaccinating” the Indian people.